Bittium and Coronaria co-operate to further develop medical remote diagnostic services

Bittium Medanalytics Oy, part of Bittium group, and Coronaria Hoitoketju’s subsidiary Coronaria Analyysipalvelut Oy, have today signed agreements according to which Bittium Medanalytics Oy sells its remote diagnostic service business to Coronaria Asiakaspalvelut Oy. According to the agreement Bittium supplies its web-based service kardiolog.fi used in monitoring cardiac abnormalities to Cornaria’s use. Kardiolog.fi service is used by more than 70 Finnish health centers and private medical centers. The net sales of Bittium Medanalytics Ltd in 2016 was EUR 0.4 million.

Further, Bittium Technologies Ltd, part of Bittium group, has acquired 25 percent of the shares in Coronaria Analyysipalvelut Oy. Through this joint ownership Bittium and Coronaria aim at gaining synergies from Bittium’s device and system development and the interfaces formed by Coronaria’s clinical medicine and services.

“This co-operation agreement with Coronaria provides us with a large network of doctors and specialists to support our medical technology development. Bittium has over 30 years of experience in radio and biosignal measuring. We believe that through this cooperation we are able to improve the healthcare services by developing even more advanced systems and devices. Through this business transaction a significant amount of out-of-hospital biosignal measurements in Finland will use Bittium’s technology in the future” says Hannu Huttunen, CEO of Bittium Corporation.

Coronaria Analyysipalvelut Oy provides biosignal measurement and web-based remote diagnostic services in Finland and its customers are private medical centers, occupational healthcare doctors and hospitals. Coronaria provides approximately 25 000 diagnostic reports per year.

”Cooperation with Bittium is a significant step for Coronaria. We believe that by combining Bittium’s technology competence and Coronaria’s exceptionally wide industry knowhow we are together able to provide high-quality, easy-to-use and secure service solutions for our customers’ everyday life” says Ulla Näpänkangas, Managing Director of Coronaria Analyysipalvelut Oy.

The sale of the services business and share purchase agreement have no significant impact on Bittium Corporation’s operating result outlook for 2017 published in the Financial Statement Bulletin 2016 on February 20, 2017. The parties have agreed that the value of the transaction will not be published.

In its Medical Technologies product and services area Bittium provides among others Faros product family, focused on ECG recording and remote monitoring, NeurOne products focusing on measuring the electrical activity of the brain, and BrainStatus, a disposable quick EEG measuring headband used in emergency and intensive primary care to diagnose for example epileptic seizures and brain stroke, and other healthcare technology products. Bittium continues to develop these products further targeting to grow its product and service offering to healthcare and homecare markets.

Bittium exhibits its innovative products and solutions for cardiology at EHRA Europace - Cardiostim 2017 Press release

 Bittium exhibits its innovative products and solutions for cardiology at EHRA Europace - Cardiostim 2017 on June 18-21 in Wien, Austria. The event will cover all aspects of heart pacing and electrophysiology, as well as provide attendees with the latest in science and education in the field of cardiac rhythm disorders and therapies.

The products and solutions exhibited are Faros ECG Event and Faros ECG Mobile software solutions focused on remote heart monitoring, Faros Cardiac Rehab monitoring solution, BrainStatus compact EEG amplifier and the 3-in-1 Faros ECG product line.

• Faros is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. Faros is ultra-small and lightweight, which enables precise long-term full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functioning.

The Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of the Faros device are used for event recording and mobile event monitoring that enable earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster. The new, innovative and sophisticated Holter analysis software increases the accuracy and speeds up the analyzing work significantly.

• Faros ECG Event and Faros ECG Mobile are software solutions for remote heart monitoring, where the cardiac arrhythmia identified by the detection algorithms embedded in the Faros device are quickly passed to professionals for examination. The solutions enable earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster.
• Faros Cardiac Rehab is a solution for cardiac rehabilitation real-time monitoring for up to 16 patients simultaneously. The system offers safety and efficiency for cardiac rehabilitation by showing each patient’s heart rate, ECG and changes in ST-segment. Utilization of the latest wireless technology allows complete freedom to choose different exercises in various training environments.

Bittium exhibits its innovative products and solutions for cardiology and neurology at Arab Health 2017 exhibition

  Bittium exhibits its innovative products and solutions for cardiology and neurology at Arab Health 2017 exhibition on January 30th – February 2nd in Dubai, the United Arab Emirates. In November 2016 Bittium acquired the healthcare technology company Mega Electronics Ltd, specialized in biosignal measuring for cardiology, neuroscience, neurophysiology, rehabilitation, occupational health and sports medicine.

The products and solutions exhibited are Faros ECG Event and Faros ECG Mobile software solutions focused on remote heart monitoring, Faros Cardiac Rehab monitoring solution, BrainStatus compact EEG amplifier and the 3-in-1 Faros ECG product line.

• Faros ECG Event and Faros ECG Mobile are software solutions for remote heart monitoring, where the cardiac arrhythmia identified by the detection algorithms embedded in the Faros device are quickly passed to professionals for examination. The solutions enable patients’ earlier repatriation and even better ability to react to potentially emerging arrhythmias faster.
• Faros Cardiac Rehab is a solution for Cardiac rehabilitation real-time monitoring for up to 16 patients simultaneously. The solution enables more effective rehabilitation of the patients and increases their safety during training.
• BrainStatus is a wireless compact EEG amplifier, which is used together with a disposable easy and quick to wear BrainStatus electrode headband for example to diagnose epileptic seizures and brain stroke. BrainStatus enables quick measurement in field conditions as well as in hospitals, thus making the treatment process of the patient faster.
• NeurOne is one of the most accurate and quickest EEG measuring devices in the world designed for research and clinical use. NeurOne system enables fully synchronized group measuring of up to 30 persons simultaneously for example in different types of psychological studies. The solution is optimized for use with transcranial magnetic stimulators (TMS-EEG), with optional possibility to use during magnetic resonance imaging procedures (fMRI-EEG).

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Starting from November 10th, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales of continuing operations in 2015 was EUR 56.8 million and operating profit was EUR 2.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com.